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In mouse models the genetic deletion of TWIK-related acid-sensitive K (TASK)-1 and TASK-3 channels removes an important background K current that results in a marked depolarization of adrenal zona glomerulosa cell membrane potential, leading to the autonomous overproduction of aldosterone. The importance of TASK channel dysfunction in human primary aldosteronism (PAL) however, is uncertain, motivating their molecular analysis. We screened coding exons and Á anking intronic sequences of KCNK3 and KCNK9 (genes coding for TASK 1 and TASK 3 respectively) in 825 PAL patients for germline DNA sequence variants. A total of 14 different coding sequence variants were found in 19 patients. The variants include 8 different synonymous mutations and 6 different missense variants. In silico predictions (PolyPhen, SIFT and Alamut) suggested the non-synonymous mutations to be potentially damaging. Analysis of mutated channel function by heterologous expression, however, revealed the missense mutations detected were non-functional. As somatic mutations may be involved in some cases of sporadic PAL, sequencing 90 patients for tumoral DNA sequence variants is underway. We are also investigating expression of TASK 1 and TASK 3 by in-situ hybridization and immunohistochemistry on adrenal tissue sections of 150 PAL patients who have undergone surgery. Background -Although estrogen administration to hysterectomized menopausal women did not prevent the occurence of myocardial infarction in a randomized controlled trial (WHI 2004) , epidemiological studies suggest and experimental results clearly demonstrate a major atheroprotective action of estrogens. The goal of the present study was to identify the cellular target(s) accounting for the estradiol (E2) beneÀ cial action on fatty streak development.
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ENDOTHELIAL ESTROGEN RECEPTOR ALPHA MEDIATES THE ATHEROPROTECTIVE ACTION OF ESTRADIOL IN LDLR DEFICIENT MICE
Methods and Results -We À rst conÀ rmed the key role of estrogen receptor α (ERα) in atheroprotective effect of E2 as this action was completely abolished in mice deÀ cient both in Low Density Lipoprotein receptor (LDLr) and in ERα. Comparison of LDLr-/-mice transplanted with either ERα+/+ or ERα-/-bone marrow showed that functional ERα in the hematopoietic lineage is not required for E2 atheroprotection. We then showed that ERα Á oxed mice (ERαÁ ox/Á ox) bred with the Tie2-Cre mice on the LDLr-/-background had a complete inactivation of ERα both in bone marrow and in endothelial cells. Remarkably, in this mouse model, the E2 atheroprotective action was completely abolished.
Conclusions -Altogether, this is the À rst in vivo demonstration that endothelial ERα represents a key target of the atheroprotective effect of E2, whereas the hematopoietic ERα is dispensable for the protective action. Selective estrogen receptor modulators that mimic this endothelial action of E2 should now be considered in hormonal treatment as well as in atheroprotection.
